CompletedPhase 1NCT05769478
Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA
Studying Botulism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wake Forest University Health Sciences
- Principal Investigator
- James B Caress, MDWake Forest University Health Sciences
- Intervention
- Amifampridine(drug)
- Enrollment
- 21 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05769478 on ClinicalTrials.govOther trials for Botulism
Additional recruiting or active studies for the same condition.